David Chiu1, Richard P Klucznik2, Tanya N Turan2, Michael J Lynn2, Charles D McCane2, Lawrence B Katz2, Azhar Nizam2, Colin P Derdeyn2, David Fiorella2, Bethany F Lane2, Jean Montgomery2, Scott Janis2, Marc I Chimowitz2. 1. From Houston Methodist Hospital (D.C., R.P.K., C.D.M., L.B.K.), Weill Cornell Medical College, TX; Medical University of South Carolina (T.N.T., M.I.C.), Charleston; Emory University Rollins School of Public Health (M.J.L., A.N., B.F.L., J.M.), Atlanta, GA; Washington University School of Medicine (C.P.D.), St Louis, MO; State University of New York (D.F.), Stony Brook; and National Institute of Neurological Disorders and Stroke (S.J.), National Institute of Health, Bethesda, MD. dchiu@tmhs.org. 2. From Houston Methodist Hospital (D.C., R.P.K., C.D.M., L.B.K.), Weill Cornell Medical College, TX; Medical University of South Carolina (T.N.T., M.I.C.), Charleston; Emory University Rollins School of Public Health (M.J.L., A.N., B.F.L., J.M.), Atlanta, GA; Washington University School of Medicine (C.P.D.), St Louis, MO; State University of New York (D.F.), Stony Brook; and National Institute of Neurological Disorders and Stroke (S.J.), National Institute of Health, Bethesda, MD.
Abstract
OBJECTIVE: The role of physician experience and patient volumes on the outcome of surgical or endovascular procedures has been well-studied but there are limited data on how these factors affect the outcome of medical therapy. METHODS: In the stenting and medical cohorts of the Stenting and Aggressive Medical Management for the Prevention of Recurrent Ischemic Stroke (SAMMPRIS) trial, we compared Kaplan-Meier (K-M) curves for the primary endpoint (any stroke or death within 30 days of enrollment or ischemic stroke in the territory beyond 30 days) using the log-rank test and the percentages of patients achieving target levels for primary and secondary risk factors during the study using Fisher exact test between patients at high-enrolling (≥12 patients) vs low-enrolling (<12 patients) sites. RESULTS: In the stenting group, the K-M curves for the primary endpoint were similar at high-enrolling sites and low-enrolling sites (p = 0.93) with rates of 13.5% vs 14.7% at 30 days and 19.0% vs 20.6% at 2 years. In the medical group, the K-M curves differed between high-enrolling sites and low-enrolling sites (p = 0.0005) with rates of 1.8% vs 9.8% at 30 days and 7.3% vs 20.9% at 2 years. The percentages of patients who achieved targets for low-density lipoprotein cholesterol and systolic blood pressure at high- vs low-enrolling sites in both treatment groups combined were 64% vs 49% (p = 0.003) and 70% vs 59% (p = 0.026), respectively. CONCLUSIONS: High-enrolling sites in SAMMPRIS achieved better control of primary risk factors and much lower rates of the primary endpoint than low-enrolling sites in the medical group, suggesting that experience with medical management is an important determinant of patient outcome.
RCT Entities:
OBJECTIVE: The role of physician experience and patient volumes on the outcome of surgical or endovascular procedures has been well-studied but there are limited data on how these factors affect the outcome of medical therapy. METHODS: In the stenting and medical cohorts of the Stenting and Aggressive Medical Management for the Prevention of Recurrent Ischemic Stroke (SAMMPRIS) trial, we compared Kaplan-Meier (K-M) curves for the primary endpoint (any stroke or death within 30 days of enrollment or ischemic stroke in the territory beyond 30 days) using the log-rank test and the percentages of patients achieving target levels for primary and secondary risk factors during the study using Fisher exact test between patients at high-enrolling (≥12 patients) vs low-enrolling (<12 patients) sites. RESULTS: In the stenting group, the K-M curves for the primary endpoint were similar at high-enrolling sites and low-enrolling sites (p = 0.93) with rates of 13.5% vs 14.7% at 30 days and 19.0% vs 20.6% at 2 years. In the medical group, the K-M curves differed between high-enrolling sites and low-enrolling sites (p = 0.0005) with rates of 1.8% vs 9.8% at 30 days and 7.3% vs 20.9% at 2 years. The percentages of patients who achieved targets for low-density lipoprotein cholesterol and systolic blood pressure at high- vs low-enrolling sites in both treatment groups combined were 64% vs 49% (p = 0.003) and 70% vs 59% (p = 0.026), respectively. CONCLUSIONS: High-enrolling sites in SAMMPRIS achieved better control of primary risk factors and much lower rates of the primary endpoint than low-enrolling sites in the medical group, suggesting that experience with medical management is an important determinant of patient outcome.
Authors: Brahmajee K Nallamothu; Hitinder S Gurm; Henry H Ting; Philip P Goodney; Mary A M Rogers; Jeptha P Curtis; Justin B Dimick; Eric R Bates; Harlan M Krumholz; John D Birkmeyer Journal: JAMA Date: 2011-09-28 Impact factor: 56.272
Authors: Marc I Chimowitz; Michael J Lynn; Tanya N Turan; David Fiorella; Bethany F Lane; Scott Janis; Colin P Derdeyn Journal: J Stroke Cerebrovasc Dis Date: 2011 Jul-Aug Impact factor: 2.136
Authors: Colin P Derdeyn; David Fiorella; Michael J Lynn; Stanley L Barnwell; Osama O Zaidat; Philip M Meyers; Y Pierre Gobin; Jacques Dion; Bethany F Lane; Tanya N Turan; L Scott Janis; Marc I Chimowitz Journal: J Neurointerv Surg Date: 2012-09-12 Impact factor: 5.836
Authors: Tanya N Turan; Michael J Lynn; Azhar Nizam; Bethany Lane; Brent M Egan; Ngoc-Anh Le; Maria F Lopes-Virella; Kathie L Hermayer; Oscar Benavente; Carole L White; W Virgil Brown; Michelle F Caskey; Meghan R Steiner; Nicole Vilardo; Andrew Stufflebean; Colin P Derdeyn; David Fiorella; Scott Janis; Marc I Chimowitz Journal: Circ Cardiovasc Qual Outcomes Date: 2012-09-01
Authors: Marc I Chimowitz; Michael J Lynn; Colin P Derdeyn; Tanya N Turan; David Fiorella; Bethany F Lane; L Scott Janis; Helmi L Lutsep; Stanley L Barnwell; Michael F Waters; Brian L Hoh; J Maurice Hourihane; Elad I Levy; Andrei V Alexandrov; Mark R Harrigan; David Chiu; Richard P Klucznik; Joni M Clark; Cameron G McDougall; Mark D Johnson; G Lee Pride; Michel T Torbey; Osama O Zaidat; Zoran Rumboldt; Harry J Cloft Journal: N Engl J Med Date: 2011-09-07 Impact factor: 91.245
Authors: David Fiorella; Colin P Derdeyn; Michael J Lynn; Stanley L Barnwell; Brian L Hoh; Elad I Levy; Mark R Harrigan; Richard P Klucznik; Cameron G McDougall; G Lee Pride; Osama O Zaidat; Helmi L Lutsep; Michael F Waters; J Maurice Hourihane; Andrei V Alexandrov; David Chiu; Joni M Clark; Mark D Johnson; Michel T Torbey; Zoran Rumboldt; Harry J Cloft; Tanya N Turan; Bethany F Lane; L Scott Janis; Marc I Chimowitz Journal: Stroke Date: 2012-09-13 Impact factor: 7.914
Authors: Colin P Derdeyn; Marc I Chimowitz; Michael J Lynn; David Fiorella; Tanya N Turan; L Scott Janis; Jean Montgomery; Azhar Nizam; Bethany F Lane; Helmi L Lutsep; Stanley L Barnwell; Michael F Waters; Brian L Hoh; J Maurice Hourihane; Elad I Levy; Andrei V Alexandrov; Mark R Harrigan; David Chiu; Richard P Klucznik; Joni M Clark; Cameron G McDougall; Mark D Johnson; G Lee Pride; John R Lynch; Osama O Zaidat; Zoran Rumboldt; Harry J Cloft Journal: Lancet Date: 2013-10-26 Impact factor: 79.321
Authors: Massimiliano Panella; Sara Marchisio; Romeo Brambilla; Kris Vanhaecht; Francesco Di Stanislao Journal: BMC Med Date: 2012-07-10 Impact factor: 8.775
Authors: David Calvet; Jean-Louis Mas; Ale Algra; Jean-Pierre Becquemin; Leo H Bonati; Joanna Dobson; Gustav Fraedrich; Olav Jansen; Willem P Mali; Peter A Ringleb; Gilles Chatellier; Martin M Brown; D Calvet; J L Mas; A Algra; J P Becquemin; L H Bonati; J Dobson; G Fraedrich; O Jansen; W P Mali; P A Ringleb; G Chatellier; M M Brown; A Algra; J P Becquemin; G Chatellier; J L Mas; G Fraedrich; P A Ringleb; O Jansen; M M Brown Journal: Stroke Date: 2013-12-17 Impact factor: 7.914